View More Recent Stories

Mar 3, 2025 08:35AM Nuvation Bio (NUVB) Secures Up to $250 Million in Non-Dilutive Financings from Sagard Healthcare Partners
Feb 12, 2025 05:31PM Nuvation Bio executive Jerry Wang to depart after key milestones
Feb 12, 2025 11:29AM Kuehn Law Encourages Investors of Nuvation Bio Inc. to Contact Law Firm
Feb 3, 2025 08:03AM Nuvation Bio (NUVB) Announces Expanded Access Program in the U.S. for Taletrectinib in Advanced ROS1-positive Non-Small Cell Lung Cancer
Jan 13, 2025 12:50PM RBC Capital Explores Biotech Implications Following Cavazzoni's Departure from the FDA
Jan 6, 2025 07:09AM H.C. Wainwright Reiterates Buy Rating on Nuvation Bio Inc (NUVB)
Dec 23, 2024 08:03AM Nuvation Bio (NUVB) Announces FDA Acceptance for Priority Review of New Drug Application for Taletrectinib
Dec 12, 2024 01:18PM Clear Street Starts Nuvation Bio Inc (NUVB) at Buy
Nov 7, 2024 09:12AM Nuvation Bio Inc. (NUVB) Misses Q3 EPS by 1c
Oct 7, 2024 04:05PM Nuvation Bio (NUVB) Appoints Philippe Sauvage as CFO
Sep 16, 2024 06:55AM Nuvation Bio Inc (NUVB) PT Lowered to $7 at H.C. Wainwright
Aug 5, 2024 08:04AM Nuvation Bio Inc. (NUVB) Misses Q2 EPS by 183c
Jul 18, 2024 02:41PM BTIG Reiterates Buy Rating on Nuvation Bio Inc (NUVB)
View More Recent Stories